HRTX Tomasz Malinowski sells between 15,001 and 50,000 shares
Jan 01, 2025, 2:44 AM
9.15%
What does HRTX do
Heron Therapeutics, based in San Diego, develops pharmaceutical products for acute care and oncology, including SUSTOL, CINVANTI, ZYNRELEF, and APONVIE, with 126 employees. Its products are distributed in the U.S.
Representative Tomasz Malinowski sold between 15,001 and 50,000 shares of HRTX on 18 May.
📡️ Health Care
Politician Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
